Journal: bioRxiv
Article Title: Tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis in Diet-induced Obesity Model
doi: 10.64898/2025.12.18.695152
Figure Lengend Snippet: Veh = vehicle, Lep = leptin (LY355101), TZP = tirzepatide, PF = pair-feeding, SC = subcutaneous, POMC = pro-opiomelanocortin, ARH = arcuate nucleus of hypothalamus, GLP1-R = glucagon-like peptide-1 receptor, pSTAT3 = phosphorylated STAT3. (A) Schematic illustration of the study design (6 dosing groups: Veh + Veh, Veh + Lep, TZP + Veh, TZP + Lep, PF + Veh, PF + Lep). n = 8 per group. (B) Representative images of Agrp and Pomc positive cells co-expressing pSTAT3 protein. (C) Representative images of Glp1r+, Gipr+ cells and pSTAT3 protein expression. (D) Percentage of Pomc+/pSTAT3+ cells out of all Pomc+ cells in ARH, calculated as the average of 3 sections. n = 7-8. Dunnett’s test one-factor linear model. # P < 0.05 compared to TZP/Veh. (E) Percentage of Glp1r+/pSTAT3+ cells out of all Glp1r+ cells in ARH, calculated as the average of 3 sections. n = 7-8. Dunnett’s test one-factor linear model. ## P < 0.01 compared to TZP/Veh. (F-H) qPCR analysis of Socs3, Pomc, and Npy in the hypothalamus from DIO mice after 3 weeks of reagent treatment. n = 6-9 per group. One-way ANOVA. *p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001. Data are displayed as means ± SEM.
Article Snippet: Formalin-fixed paraffin-embedded brain sections (3 sections per mouse per triplex) underwent RNAscope in situ RNA hybridization (ISH) for the detection of Lepr (ACDBio probe #418858-C2), Glp-1r (ACDBio probe #418858-C2), Gipr (ACDBio probe #319128-C1), Pomc (ACDBio probe #314088-C2) and Agrp (ACDBio probe #400718-C1), followed by immunofluorescence (IF) staining for pSTAT3 protein (Cell Signaling anti-pSTAT3 #9145).
Techniques: Expressing